Study objective: To compare the safety of salmeterol xinafoate or placebo added to usual asthma care. Design: A 28-week, randomized, double-blind, placebo-controlled, observational study.

Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms. Israel-based Teva said the ...

The main patent on Advair (fluticasone+salmeterol) expired as long ago as ... Wixela Inhub is indicated for the twice daily treatment of asthma in patients age four and older not adequately ...

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...

You will be able to get a quick price and instant permission to reuse the content in many different ways. Exacerbations represent an important feature of the clinical manifestation and natural history ...

Medical research involves research in a wide range of fields, such as biology, chemistry, pharmacology and toxicology with the goal of developing new medicines or medical procedures or improving ...

Body & Mind Incredible progress is being made in health and medicine – every day we seem to broaden our understanding of how to maximize physical and mental health, treat and cure illness and ...

Despite a fall in the number of people with asthma over the past decade who say that cost has stopped them taking their meds as prescribed, financial hardship still remains a deterrent for 1 in 6 ...

The doctors who work in the ER at the County General Hospital in Chicago grapple with ups and downs in their personal and professional lives while trying to give apt medical care to their patients.

Researchers have found a way to program immune cells to attack glioblastoma and treat the inflammation of multiple sclerosis in mice. The gut microbiota might perhaps one day become a routine tool ...

List your movie, TV & celebrity picks.

After hours: December 6 at 7:59:02 p.m. EST ...